• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析患者体内的铝毒代动力学。

Aluminum toxicokinetics in peritoneal dialysis patients.

机构信息

Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada.

出版信息

Clin Toxicol (Phila). 2011 Aug;49(7):659-63. doi: 10.3109/15563650.2011.602083. Epub 2011 Aug 8.

DOI:10.3109/15563650.2011.602083
PMID:21819285
Abstract

CONTEXT

Despite the risk of aluminum (Al) toxicity in dialysis patients, little is known about its toxicokinetics (TK) in this population. A national contamination of dialysate solutions with Al provided the opportunity to study Al TK in peritoneal dialysis (PD) patients and to better understand the influence of covariates on its disposition.

METHODS

Al levels in serum and dialysate as well as other laboratory values were collected prospectively from 83 PD patients after correction of Al contamination. Population TK analyses were conducted with NONMEM VI using standard model discrimination criteria. Covariate analyses were also performed using stepwise forward regression followed by backward deletion.

RESULTS

After correction of Al exposure, serum levels declined in a biphasic manner, which was captured by the TK model. The TK of Al were best described by a 2-compartment model with linear elimination. Total creatinine clearance was a significant covariate for total clearance (CL). Mean parameter estimates for volume of central compartment (V1), CL, volume of peripheral compartment (V2), volume of distribution at steady-state (Vss), and intercompartmental clearance (Q) were 168 L, 8.99 L/day, 12 000 L, 12 168 L, and 4.93 L/day, respectively. Inter-individual variability for CL and V2 were 22.6 and 51.1%, respectively. Al distributional half-life was 8.5 days, while the terminal elimination half-life was 7.2 years. This model confirms that the large Vss reflects the widespread distribution of Al in bone, lungs, liver, and other tissues.

CONCLUSION

This study describes the first population Al TK model in a large group of PD patients, which includes a covariate effect. The model confirms the extensive half-life and tissue distribution of Al in a dialysis-dependent population.

摘要

背景

尽管透析患者存在铝(Al)毒性风险,但人们对其在该人群中的毒代动力学(TK)知之甚少。全国范围内的透析液污染事件为研究腹膜透析(PD)患者的 Al TK 提供了机会,并使人们更好地了解了各种协变量对其处置的影响。

方法

在纠正 Al 污染后,前瞻性地从 83 名 PD 患者中收集血清和透析液中的 Al 水平以及其他实验室值。使用 NONMEM VI 通过标准模型鉴别标准进行群体 TK 分析。还使用逐步向前回归和向后删除进行协变量分析。

结果

在纠正 Al 暴露后,血清水平呈双相下降,这一过程由 TK 模型捕捉到。Al 的 TK 最好用具有线性消除的 2 室模型来描述。总肌酐清除率是总清除率(CL)的重要协变量。中央室容积(V1)、CL、周边室容积(V2)、稳态分布容积(Vss)和隔室间清除率(Q)的平均参数估计值分别为 168 L、8.99 L/天、12000 L、12168 L 和 4.93 L/天。CL 和 V2 的个体间变异性分别为 22.6%和 51.1%。Al 分布半衰期为 8.5 天,而终末消除半衰期为 7.2 年。该模型证实,大 Vss 反映了 Al 在骨骼、肺、肝和其他组织中的广泛分布。

结论

本研究描述了首个在大量 PD 患者中进行的群体 Al TK 模型,其中包括协变量的影响。该模型证实了在透析依赖人群中 Al 的广泛半衰期和组织分布。

相似文献

1
Aluminum toxicokinetics in peritoneal dialysis patients.腹膜透析患者体内的铝毒代动力学。
Clin Toxicol (Phila). 2011 Aug;49(7):659-63. doi: 10.3109/15563650.2011.602083. Epub 2011 Aug 8.
2
Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).持续非卧床腹膜透析(CAPD)患者血清、透析液、尿液和骨骼中的铝浓度。
Clin Nephrol. 1989 Sep;32(3):133-8.
3
[Elimination of aluminum via continuous ambulatory peritoneal dialysis].[通过持续非卧床腹膜透析清除铝]
Dtsch Med Wochenschr. 1989 Jan 6;114(1):9-13. doi: 10.1055/s-2008-1066543.
4
Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.HER2酪氨酸激酶抑制剂CP-724,714在晚期恶性HER2阳性实体瘤患者中的群体药代动力学
Cancer Chemother Pharmacol. 2007 Nov;60(6):799-809. doi: 10.1007/s00280-007-0427-6. Epub 2007 Feb 7.
5
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.雷替曲塞在晚期实体瘤患者中的群体药代动力学。
Br J Clin Pharmacol. 2004 Apr;57(4):416-26. doi: 10.1111/j.1365-2125.2003.02050.x.
6
Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis.齐多夫定在五名接受持续性非卧床腹膜透析的HIV血清阴性患者中的药代动力学。
Pharmacotherapy. 1992;12(1):56-60.
7
Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.丙泊酚用于重症患者长期镇静的群体药代动力学和药效学建模:丙泊酚6%与丙泊酚1%的比较
Clin Pharmacol Ther. 2002 Dec;72(6):670-84. doi: 10.1067/mcp.2002.129500.
8
Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.低 GDP 液(甘丙肽三联)可减缓 PD 患者残余肾功能下降:一项前瞻性随机研究。
Nephrol Dial Transplant. 2010 Jul;25(7):2288-96. doi: 10.1093/ndt/gfq087. Epub 2010 Mar 1.
9
Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.重度营养不良儿童每日单次肌内注射庆大霉素的群体药代动力学
J Antimicrob Chemother. 2007 Apr;59(4):681-9. doi: 10.1093/jac/dkl561. Epub 2007 Mar 8.
10
Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.低剂量阿霉素及其代谢产物在艾滋病相关卡波西肉瘤患者中的药代动力学
Cancer Chemother Pharmacol. 2005 May;55(5):488-96. doi: 10.1007/s00280-004-0900-4. Epub 2005 Feb 23.

引用本文的文献

1
Assessment of Potential Toxic Heavy Metal Levels in Serum of Saudi Patients Under Regular Hemodialysis and Its Association with Parathyroid Hormone, Uremic Pruritus, and Anemia.沙特定期血液透析患者血清中潜在有毒重金属水平的评估及其与甲状旁腺激素、尿毒症瘙痒和贫血的关系。
Toxics. 2025 Mar 24;13(4):241. doi: 10.3390/toxics13040241.
2
Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis.血液铝水平在血液透析和腹膜透析患者中的变化。
Int J Environ Res Public Health. 2022 Mar 24;19(7):3885. doi: 10.3390/ijerph19073885.
3
Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging.
用于体内正电子发射断层扫描成像的层状双氢氧化物纳米颗粒的无螯合剂标记
Sci Rep. 2015 Nov 20;5:16930. doi: 10.1038/srep16930.
4
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.对药物、职业和消费者接触金属及纳米级铝、氧化铝、氢氧化铝及其可溶性盐所带来的潜在健康风险的系统评价。
Crit Rev Toxicol. 2014 Oct;44 Suppl 4(Suppl 4):1-80. doi: 10.3109/10408444.2014.934439.
5
Layered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement.用于药物递送系统的层状双氢氧化物纳米复合材料;生物分布、毒性及药物活性增强
Chem Cent J. 2014 Aug 10;8(1):47. doi: 10.1186/s13065-014-0047-2. eCollection 2014.
6
Aluminum transfer during dialysis: a systematic review.透析过程中的铝转运:一项系统评价。
Int Urol Nephrol. 2014 Jul;46(7):1361-5. doi: 10.1007/s11255-014-0752-8. Epub 2014 Jun 18.
7
Zinc supplementation alters plasma aluminum and selenium status of patients undergoing dialysis: a pilot study.补锌对透析患者血浆铝和硒状态的影响:一项初步研究。
Nutrients. 2013 Apr 22;5(4):1456-70. doi: 10.3390/nu5041456.